Quick Answer
Prime Medicine, Inc. reported Revenue (ASC 606) of $4.63 million for fiscal year 2025.
Prime Medicine, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $4.63M | +55.3% |
| 2024 | $2.98M | — |
| 2023 | $0.00 | — |
| 2022 | $0.00 | — |
| 2021 | $0.00 | -100.0% |
| 2020 | $5.21M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.23M | +486.1% | +9.9% |
| June 30, 2025 | $1.11M | — | -23.3% |
| March 31, 2025 | $1.45M | +146.0% | +595.7% |
| September 30, 2024 | $209.0K | — | — |
| June 30, 2024 | $0.00 | — | -100.0% |
| March 31, 2024 | $591.0K | — | — |
| September 30, 2023 | $0.00 | — | — |
| June 30, 2023 | $0.00 | — | — |
- Prime Medicine, Inc. showed an increase of +55.3% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2020–2025 period, Prime Medicine, Inc.’s revenue (asc 606) has declined by 11.1% (from $5.21 million to $4.63 million).
- The most recent figure is from Prime Medicine, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: